BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32127038)

  • 1. Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions.
    Ortiz-Hernandez GL; Sanchez-Hernandez ES; Casiano CA
    Auto Immun Highlights; 2020 Feb; 11(1):3. PubMed ID: 32127038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
    Türkoğlu G; Berkem R; Karakoç AE
    Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies].
    Çetin Duran A; Barut K; Duran A; Eren Dağlar D
    Mikrobiyol Bul; 2021 Jul; 55(3):415-425. PubMed ID: 34416806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer.
    Basu A; Sanchez TW; Casiano CA
    Front Immunol; 2015; 6():116. PubMed ID: 25852687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.
    Ochs RL; Mahler M; Basu A; Rios-Colon L; Sanchez TW; Andrade LE; Fritzler MJ; Casiano CA
    Clin Exp Med; 2016 Aug; 16(3):273-93. PubMed ID: 26088181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
    J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75.
    Sanchez-Hernandez ES; Ortiz-Hernandez GL; Ochoa PT; Reeves M; Bizzaro N; Andrade LEC; Mahler M; Casiano CA
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel magnetic bead-based immunoprecipitation method for anti-dense fine speckled 70 antibodies.
    Chen R; Wei X; Yang C; Nguyen K
    Pathology; 2023 Oct; 55(6):843-849. PubMed ID: 37336684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Relevance of Anti-DFS70 Autoantibodies.
    Conrad K; Röber N; Andrade LE; Mahler M
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z; Demir M
    J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate.
    Malyavantham K; Suresh L
    Auto Immun Highlights; 2017 Dec; 8(1):3. PubMed ID: 28315185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
    Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
    Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
    La Jeon Y; Kang SY; Lee WI; Kim MH
    Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-DFS70: significance and clinical utility of a new anti-nuclear antibody].
    Roux-Lombard P
    Rev Med Suisse; 2021 Mar; 17(729):470-475. PubMed ID: 33689242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2.
    Basu A; Woods-Burnham L; Ortiz G; Rios-Colon L; Figueroa J; Albesa R; Andrade LE; Mahler M; Casiano CA
    Clin Immunol; 2015 Dec; 161(2):241-50. PubMed ID: 26235378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
    Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
    Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.